Skip to main content
Clinical Trials/IRCT20161108030776N4
IRCT20161108030776N4RecruitingPhase 3

The effect of ethanolic extract of Elaeagnus angustifolia flower on sexual dysfunction in women with multiple sclerosis (MS): A double-blind randomized clinical trial

Kerman University of Medical Sciences0 sites92 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
92

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
no limit to no limit (—)
Sex
Female

Inclusion Criteria

  • Women with MS in reproductive age and meta-males who have a constant sexual partner
  • Sexual dysfunction confirmed by the test (Female Sexual Function Index (FSFI)
  • Normal pelvic examination
  • Pap smear negative in the last six months
  • Normal breast examination

Exclusion Criteria

  • Suffering from a serious disease other than MS (any disease other than MS that requires the participant to use non-MS medications during the study)
  • Any history of genital or gastrointestinal or breast cancer
  • pregnancy and breastfeeding
  • Suffering from depression or other mental disordersand taking antidepressants

Investigators

Similar Trials

The effect of Elaeagnus angustifolia... | Clinical Trial